Peripheral arterial disease Circulatory System Peripheral vascular disease, unspecified
Conditions
Interventions
The intervention used in this research is called "LEGS". It was developed by patients and experts in peripheral arterial disease. It addresses the five key treatment areas (i.e. best medical therapy)
Sponsors
University of Leicester
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients: 1. Adult (>18 years of age) patient with incapacitating intermittent claudication or chronic limb threatening ischaemia (Rutherford stages 3–6) 2. Referred to secondary care, either in a clinic or for inpatient treatment 3. Willing and able to give written informed consent for participation in the study 4. Access to a telephone or computer with internet access (for those taking part in remote interviews/consensus meeting) Healthcare professionals: 5. Healthcare professionals who provide care to patients with have symptomatic peripheral arterial disease
Exclusion criteria
Exclusion criteria: 1. Female participants who are pregnant, lactating or planning a pregnancy during the course of the study 2. Patients who do not have the capacity to consent for themselves 3. Patients with a life-limiting condition whereby conservative management is most appropriate 4. Patients with asymptomatic peripheral arterial disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of elements of the LEGS intervention delivered successfully by the clinical team measured using patient records at day of discharge/day of clinic appointment and 15 days later | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Has the participant been made aware of the diagnosis of peripheral arterial disease and whether relevant medications have been prescribed? (yes/no) by contacting the primary care surgery at day 15 2. Patient medication history from day 0 to 6 months, measured using patient records 3. Health events from day 0 to 6 months, measured using patient records 4. Quality of life measured using the EuroQol-5D (EQ-5D) questionnaire at 6 months | — |
Countries
England, United Kingdom
Contacts
Public ContactAnn Elsworth
Outcome results
None listed